Clinical Trials Browser

Phase 2 × Withdrawn × antineoplaston AS 2-1 × Clear all

NCT00003534 2018-01-31

Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT00003455 2013-07-10

Antineoplaston Therapy in Treating Women With Advanced Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms

NCT00003486 2013-07-10

Antineoplaston Therapy in Treating Patients With Colon Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT00003502 2013-07-10

Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma

Phase 2 Withdrawn

Lymphoma, Mantle-Cell

NCT00003517 2013-07-10

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms